• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Disc Medicine, Inc. - Common Stock (NQ:IRON)

    80.36 -2.19 (-2.65%)
    Streaming Delayed Price Updated: 2:09 PM EDT, Aug 28, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 428,197
    Open 81.79
    Bid (Size) 80.25 (100)
    Ask (Size) 80.47 (100)
    Prev. Close 82.55
    Today's Range 80.30 - 82.70
    52wk Range 40.00 - 99.50
    Shares Outstanding 22,877,552
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    Disc Medicine Reports Second Quarter 2026 Financial Results and Provides Business Update
    From Disc Medicine Inc
    Via GlobeNewswire

    Performance

    YTD
    +1.6%
    +1.6%
    1 Month
    +7.6%
    +7.6%
    3 Month
    +13.5%
    +13.5%
    6 Month
    +18.3%
    +18.3%
    1 Year
    +34.0%
    +34.0%

    More News

    Read More
    News headline image
    Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    Disc Medicine Presents Positive Clinical Updates at the 2026 European Hematology Association (EHA) Annual Meeting
    From Disc Medicine Inc
    Via GlobeNewswire
    News headline image
    Disc Medicine Provides Update from FDA Type A Meeting for Bitopertin in Erythropoietic Protoporphyria
    From Disc Medicine Inc
    Via GlobeNewswire
    News headline image
    IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    Disc Medicine Presents Updated Positive Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
    From Disc Medicine Inc
    Via GlobeNewswire
    News headline image
    Disc Medicine Launches Expanded Access Program for Bitopertin for EPP Patients
    From Disc Medicine Inc
    Via GlobeNewswire
    News headline image
    Disc Medicine Eyes Mid-2026 Bitopertin Approval as EPP Trial Demand Surges ↗
    Via MarketBeat
    News headline image
    Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2026 Congress
    From Disc Medicine Inc
    Via GlobeNewswire
    News headline image
    Disc Medicine to Participate in Upcoming Investor Conferences
    From Disc Medicine Inc
    Via GlobeNewswire
    News headline image
    IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    Disc Medicine Reports First Quarter 2026 Financial Results and Provides Business Update
    From Disc Medicine Inc
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    Disc Medicine Insider Sells $380K in Stock Amid 70% One-Year Surge ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Disc Medicine Announces Oral Presentation of Data from RALLY-MF Phase 2 Trial of DISC-0974 in Patients with Myelofibrosis and Anemia at the American Society of Clinical Oncology (ASCO) Annual Meeting
    From Disc Medicine Inc
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    Disc Medicine Announces Completion of Enrollment of Phase 3 APOLLO Trial of Bitopertin in Erythropoietic Protoporphyria
    From Disc Medicine Inc
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Disc Medicine, Inc. – IRON
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation – IRON
    From The Rosen Law Firm, P.A.
    Via Business Wire

    Frequently Asked Questions

    Is Disc Medicine, Inc. - Common Stock publicly traded?
    Yes, Disc Medicine, Inc. - Common Stock is publicly traded.
    What exchange does Disc Medicine, Inc. - Common Stock trade on?
    Disc Medicine, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Disc Medicine, Inc. - Common Stock?
    The ticker symbol for Disc Medicine, Inc. - Common Stock is IRON on the Nasdaq Stock Market
    What is the current price of Disc Medicine, Inc. - Common Stock?
    The current price of Disc Medicine, Inc. - Common Stock is 80.36
    When was Disc Medicine, Inc. - Common Stock last traded?
    The last trade of Disc Medicine, Inc. - Common Stock was at 08/28/26 02:09 PM ET
    What is the market capitalization of Disc Medicine, Inc. - Common Stock?
    The market capitalization of Disc Medicine, Inc. - Common Stock is 1.84B
    How many shares of Disc Medicine, Inc. - Common Stock are outstanding?
    Disc Medicine, Inc. - Common Stock has 2B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.